I fully expect Innovata to be floated off for around £12 mln, leaving MLB with what is really the core business - the bits I once expected would have to go with Cobra, when we were in the depths of despair cash-wise.
OK, £12 mln is too cheap on the face of it, but not if that sum gets us to where we seem to be heading with the cancer treatments.
Share price fluctuations are fairly irrelevant to the long-term prognosis. I hold for the longer term, having bought at 44.5p /12.85p,averaging 23p.
The short-termism of the recent placees is depressing to behold. That is why I am a private investor.
-------------------